![Jeff Baxter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Baxter
Vorstandsvorsitzender bei
VBI Vaccines (Delaware), Inc.
Profil
Jeffrey R. Baxter ist President, Chief Executive Officer & Director bei VBI Vaccines, Inc. und ein unabhängiger Non-Executive Director bei Chromadex Corp. sowie President, Chief Executive Officer & Director bei VBI Vaccines (Delaware), Inc. und President, Chief Executive Officer & Director bei Variation Biotechnologies (US), Inc. Er ist Mitglied des Board of Directors bei VBI Vaccines, Inc. und Chromadex Corp. sowie bei VBI Vaccines (Delaware), Inc. und Variation Biotechnologies (US), Inc. Herr Baxter war zuvor als SVP-Finance, Operations, Research & Development bei GlaxoSmithKline Plc, als Principal bei British American Tobacco plc, als Managing Partner bei The Column Group LLC und als Principal bei Unilever Plc tätig. Er erhielt seinen Bachelor-Abschluss von der Thames Valley University.
Aktive Positionen von Jeff Baxter
| Unternehmen | Position | Beginn |
|---|---|---|
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Präsident | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Vorstandsvorsitzender | 01.07.2014 |
Ehemalige bekannte Positionen von Jeff Baxter
| Unternehmen | Position | Ende |
|---|---|---|
| VBI VACCINES INC. | Vorstandsvorsitzender | 03.01.2025 |
| NIAGEN BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 04.04.2022 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Chief Investment Officer | 28.02.2009 |
| GSK PLC | Corporate Officer/Principal | 01.07.2006 |
| UNILEVER PLC | Corporate Officer/Principal | - |
Ausbildung von Jeff Baxter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
British American Tobacco plc
 British American Tobacco plc TobaccoConsumer Non-Durables Manufactures and supplies tobacco products | Consumer Non-Durables |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
University of West London
 University of West London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
